Panelists discuss how the future treatment landscape for myeloproliferative neoplasms is evolving with many promising ...

Panelists discuss how rusfertide, a hepcidin mimetic peptide, shows promise in polycythemia vera by reducing phlebotomy ...

A rare case of Epstein-Barr virus-induced Bell palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...

The finding that basophil counts may have prognostic significance aligns with a growing body of research into basophils in ...

The Centers for Disease Control (CDC) yesterday said it has raised the travel advisory for the Philippines to level 1 “watch” ...

Hematological diseases can cause massive splenomegaly and portal hypertension via portal vein thrombosis, liver infiltration by malignant cells, or in association with NRH. Myelofibrosis.

BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...

Conducted across 87 centers in France, the SplenoMegaly Study aims to investigate the causes of unexplained splenomegaly, with a particular focus on identifying cases of GD. Reference Denis G, Terriou ...